iifl-logo-icon 1

Kilitch Drugs (India) Ltd Board Meeting

314.6
(0.64%)
Nov 6, 2024|03:32:06 PM

Kilitch Drugs CORPORATE ACTIONS

07/11/2023calendar-icon
06/11/2024calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting30 Aug 202430 Aug 2024
Pursuant to Regulation 30 of SEBI LODR Regulations, this is to inform you that the Board of Directors approved the appointment of M/s C Sharat & Company, Chartered Accountants as a Statutory Auditors of the Company
Board Meeting26 Aug 202426 Aug 2024
Appointment of M/s. AVHP & Company LLP, Chartered Accountant (FRN:W100671) as Statutory Auditors of the Company
Board Meeting8 Aug 20241 Aug 2024
KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve unaudited financial results for the period ended 30th June 2024 Submission of Quarterly Standalone and Financial Results for the quarter ended 30th June 2024 (As Per BSE Announcement Dated on: 08/08/2024)
Board Meeting27 May 202420 May 2024
KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 inter alia to consider and approve financial results for the quarter and year ended 31st March 2024 Financial Results for the year ended 31st March, 2024 Quarterly financial results for the year ended 31st March, 2024 (As Per BSE Announcement Dated on 27.05.2024)
Board Meeting8 Feb 202431 Jan 2024
KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 31st December 2023 Declaration of Financial Results for the quarter ended 31st December, 2023 Submission of financial results for the quarter ended 31st December, 2023 (As Per BSE Announcement dated on 08.02.2024)
Board Meeting9 Nov 20231 Nov 2023
KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve and consider the unaudited Financial Results (Standalone and Consolidated) of the Company for the half year ended 30th September 2023. Enclosed please find Financial Results for the quarter ended 30th September, 2023 (As Per BSE Announcement dated on 09.11.2023)

Kilitch Drugs: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp